Provided by Tiger Fintech (Singapore) Pte. Ltd.

iSpecimen Inc.

1.34
+0.07005.51%
Post-market: 1.340.00000.00%19:52 EDT
Volume:35.36K
Turnover:46.44K
Market Cap:1.29M
PE:-0.08
High:1.35
Open:1.27
Low:1.27
Close:1.27
Loading ...

Company Profile

Company Name:
iSpecimen Inc.
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
53
Office Location:
450 Bedford Street,Lexington,Massachusetts,United States
Zip Code:
02420
Fax:
- -
Introduction:
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Directors

Name
Position
Andrew L. Ross
Chairman of the Board
Christopher Ianelli
Chief Executive Officer, President, and Director
Jill Mullan
Chief Operating Officer, Secretary, Treasurer, and Director
George Scholl
Director
John L. Brooks III
Director
Margaret H. Lawrence
Director
Steven Gullans
Director

Shareholders

Name
Position
Christopher Ianelli
Chief Executive Officer, President, and Director
Jill Mullan
Chief Operating Officer, Secretary, Treasurer, and Director
Tracy Curley
Chief Financial Officer
Benjamin Bielak
Chief Information Officer